Text Size
86 studies found for:    "Retinitis pigmentosa"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Active, not recruiting Transcorneal Electrostimulation for Therapy of Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Device: transcorneal electrostimulation
22 Recruiting Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: UF-021;   Drug: Placebo
23 Unknown † IRIS PILOT - Extended Pilot Study With a Retinal Implant System
Conditions: Retinitis Pigmentosa;   Cone-Rod Dystrophy;   Choroideremia
Intervention: Device: Retinal Implant System (IRIS)
24 Recruiting Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)
Condition: Retinitis Pigmentosa (RP)
Intervention: Drug: QLT091001
25 Active, not recruiting Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa;   Retinal Diseases;   Eye Diseases;   Eye Disease, Hereditary;   Retinal Degeneration
Intervention: Drug: Valproic Acid
26 Completed Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: Vitamin E;   Drug: Vitamin A
27 Recruiting Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)
Conditions: LCA (Leber Congenital Amaurosis);   RP (Retinitis Pigmentosa)
Intervention: Drug: QLT091001
28 Completed Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: docosahexaenoic acid
29 Completed Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations
Conditions: LCA (Leber Congenital Amaurosis);   RP (Retinitis Pigmentosa)
Intervention: Drug: QLT091001
30 Terminated Study of Dietary N-3 Fatty Acids in Patients With Retinitis Pigmentosa and Usher Syndrome
Conditions: Usher Syndrome;   Retinitis Pigmentosa
Intervention:
31 Completed The Role of Capsular Tension Ring (CTR) in Anterior Capsular Contraction
Conditions: Retinitis Pigmentosa;   Cataract
Intervention: Procedure: IOL surgery
32 Unknown † Evaluation of Objective Perimetry Using Pupillometer
Conditions: Retinitis Pigmentosa;   Glaucoma;   Visual Field
Intervention:
33 Completed Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the Eye
Condition: Retinitis Pigmentosa
Intervention: Drug: Ciliary Neurotrophic Factor Implant NT-501
34 Recruiting TES for the Treatment of RP
Condition: Retinitis Pigmentosa
Intervention: Device: Transcorneal electrical stimulation
35 Unknown † Autoimmunity in Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: twice-daily dosage with 0.5% cyclosporine-A eyedrops
36 Active, not recruiting Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Device: Argus 16 Retinal Stimulation System
37 Completed
Has Results 		An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: 400 µg Brimonidine Tartrate Implant;   Drug: 200 µg Brimonidine Tartrate Implant;   Drug: 100 µg Brimonidine Tartrate Implant;   Other: Sham (no implant)
38 Recruiting Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy
Conditions: Retinitis Pigmentosa,;   Cone Rod Dystrophy,;   Choroideremia
Intervention: Device: Intelligent Retinal Implant System
39 Completed The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions im Patients With Autosomal Dominant Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Dietary Supplement: Alga Dunaliella Bardawil;   Dietary Supplement: Alga Dunaliella Bardawill;   Other: Sugar pill
40 Recruiting The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil
Condition: Retinitis Pigmentosa
Interventions: Dietary Supplement: Alga Dunaliella Bardawil;   Other: Placebo (starch)
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years